Altimmune (ALT) Consolidated Net Income: 2010-2025
Historic Consolidated Net Income for Altimmune (ALT) over the last 16 years, with Sep 2025 value amounting to -$19.0 million.
- Altimmune's Consolidated Net Income rose 16.77% to -$19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.0 million, marking a year-over-year increase of 18.82%. This contributed to the annual value of -$95.1 million for FY2024, which is 7.53% down from last year.
- According to the latest figures from Q3 2025, Altimmune's Consolidated Net Income is -$19.0 million, which was up 14.14% from -$22.1 million recorded in Q2 2025.
- In the past 5 years, Altimmune's Consolidated Net Income registered a high of -$14.9 million during Q1 2021, and its lowest value of -$33.5 million during Q3 2021.
- In the last 3 years, Altimmune's Consolidated Net Income had a median value of -$22.1 million in 2025 and averaged -$22.2 million.
- As far as peak fluctuations go, Altimmune's Consolidated Net Income tumbled by 282.54% in 2021, and later grew by 29.83% in 2022.
- Altimmune's Consolidated Net Income (Quarterly) stood at -$23.9 million in 2021, then rose by 9.33% to -$21.7 million in 2022, then crashed by 46.08% to -$31.6 million in 2023, then grew by 26.37% to -$23.3 million in 2024, then climbed by 16.77% to -$19.0 million in 2025.
- Its Consolidated Net Income stands at -$19.0 million for Q3 2025, versus -$22.1 million for Q2 2025 and -$19.6 million for Q1 2025.